Andy Pasternak - Nov 1, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP and Chief Business Officer
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Nov 1, 2022
Transactions value $
-$347,680
Form type
4
Date filed
11/2/2022, 04:12 PM
Previous filing
Jul 29, 2022
Next filing
Dec 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +12.4K +36.48% 46.5K Nov 1, 2022 Direct F1
transaction HZNP Ordinary Shares Tax liability -$348K -5.5K -11.84% $63.18 41K Nov 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units Options Exercise $0 +12.4K $0.00* 0 Nov 1, 2022 Ordinary shares 12.4K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
F2 The shares subject to the restricted stock units vest in three equal annual installments, beginning November 1, 2020.